Annex

United Kingdom

The entry for lasalocid in Table 1 of the Annex to Regulation (EU) No 37/2010 is replaced by the following:

Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification
‘Lasalocid Lasalocid A Poultry 20 μg/kg Muscle NO ENTRY Anti-infectious agents/Antibiotics’
100 μg/kg Skin and fat
100 μg/kg Liver
50 μg/kg Kidney
150 μg/kg Eggs
Bovine 10 μg/kg Muscle Not for use in animals from which milk is produced for human consumption
20 μg/kg Fat
100 μg/kg Liver
20 μg/kg Kidney

Pharmacologically active Substance	Marker residue	Animal Species	MRL	Target Tissues	Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic Classification
‘Lasalocid	Lasalocid A	Poultry	20 μg/kg	Muscle	NO ENTRY	Anti-infectious agents/Antibiotics’
			100 μg/kg	Skin and fat
			100 μg/kg	Liver
			50 μg/kg	Kidney
			150 μg/kg	Eggs
		Bovine	10 μg/kg	Muscle	Not for use in animals from which milk is produced for human consumption
			20 μg/kg	Fat
			100 μg/kg	Liver
			20 μg/kg	Kidney